Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myeloid, Acute

Explore clinical trials studying Leukemia, Myeloid, Acute. Study availability and eligibility vary by location and protocol.

2,459 public trials 541 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myeloid, Acute trial results

Recruiting

A Multi-Site Break Through Cancer Trial: Phase II Study Investigating Dual Inhibition of BCL2 and Menin in AML MRD Using the Combination of Venetoclax and Revumenib

NCT06284486

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Johns Hopkins University Baltimore, Maryland, United States
  • Dana-Farber Cancer Center Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes

NCT06146257

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +7 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • University of California Irvine Irvine, California, United States
  • University of Kansas Medical Center Research Institute, Inc. Kansas City, Kansas, United States
  • Alliance for Multispecialty Research, LLC Merriam, Kansas, United States
View Trial Details
Recruiting

A Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes

NCT05732103

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +7 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Mayo Clinic Florida Jacksonville, Florida, United States
  • Northwestern University Chicago, Illinois, United States
  • Mayo Clinic Comprehensive Cancer Center Rochester, Minnesota, United States
View Trial Details
Recruiting

ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies

NCT06656494

Conditions
Acute Myelogenous Leukemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations
  • Yale University, Yale Cancer Center New Haven, Connecticut, United States
  • NYU Langone Health New York, United States
  • St Vincent's Hospital Sydney, New South Wales, Australia
  • Royal Perth Hospital Perth, Western Australia, Australia
View all 18 locations
View Trial Details
Recruiting

Study of BMS-986497 (ORM-6151) as a Monotherapy, in Double and Triple Combination With Azacitidine and Venetoclax in Participants With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome

NCT06419634

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations
  • Yale-New Haven Hospital New Haven, Connecticut, United States
  • Northwestern Memorial Hospital Chicago, Illinois, United States
  • Local Institution - 0007 Boston, Massachusetts, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View all 16 locations
View Trial Details

Related conditions